ArticleScientific reports2025
Flavonora: a new genus of lecanoroid lichens (Ascomycota, lichenized fungi).
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Chemo-Diversity and Secondary Metabolite Content in Corticolous Crustose Lichens (Fam. Arthoniaceae, Graphidaceae, Pyrenulaceae) from Remnants of Colombian Tropical Dry Forests.Journal of fungi (Basel, Switzerland) · 2026Article
- Three new sorediate species ofMycoKeys · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The systematics of lecanoroid lichens, particularly the genus Lecanora, are fraught with difficulties arising from hidden diversity and the morphological plasticity of these organisms. These challenges are further complicated in tropical regions, where despite the richness of the lichen species systematic studies exploring their diversity are still limited. Therefore, the recent molecular survey of Bolivian Lecanora s.l. revealed some taxonomic novelties including the discovery of the distinct evolutionary lineage representing a new genus, Flavonora described here. The genus Flavonora, is distinguished by the following features: brown-orange to reddish pigmentation of hypothecium and conidia if present filiform, in combination with lecanorine apothecia, large crystals always present in the amphithecium, brown-green epihymenium granulose or not, granules soluble in KOH, large spores up to 19.5 μm long, and the presence of perlatolic, 2'-O-methylperlatolic, confluentic acids, as well as usnic acid or xanthones in addition to atranorin. Comprehensive molecular data (mtSSU, nrITS, LSU, rpb1, rpb2, and mcm7) substantiates the establishment of the genus Flavonora as a new genus including the following species: Flavonora boliviana sp. nov., F. inversa comb. nov., F. fimbriatula comb. nov., and F. stramineoalbida comb. nov. (the generic type). Additionally, a focused analysis of Flavonora using mtSSU and nrITS loci was conducted to explore intrageneric relationships, revealing that F. inversa populations from Bolivia and Scotland are genetically distinct, suggesting potential cryptic speciation within this taxon.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.